IL-23 and IL-17 in ankylosing spondylitis.
Wendling
Daniel
D
D019138:Antibodies, Blocking / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D053760:Interleukin-23 Subunit p19 / Q000502:physiology*; D053722:Receptors, Interleukin-17 / Q000502:physiology*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy / Q000276:immunology*
D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; C109985:IL17RA protein, human; D053760:Interleukin-23 Subunit p19; D053722:Receptors, Interleukin-17